Trademark Details For ANGIOFLUOR (Serial Number 76354442)

  •  Home
  •  Print
ANGIOFLUOR
2
1
1
0
Serial Number  United States - USPTO 76354442
Registration Number 2628244
Mark
ANGIOFLUOR
Filing Date Jan-02-2002
Status
Registered  
REGISTERED A.. (800)
REGISTERED AND RENEWED
Attorney Name
TTAB
0



  • Mark Literal Elements:

005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Jan-01-1991

First Use in Commerce: Jan-01-1991





Correspondences

NameUsha Menon
AddressD'AMBROSIO & MENON, PLLC Suite 100 3 Sugar Creek Center Blvd. SUGAR LAND TX 77478

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Mar-20-2002ASSIGNED TO EXAMINER   DOCKD
Mar-26-2002EXAMINER'S AMENDMENT MAILED   CNEAF
Apr-03-2002APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Jun-19-2002NOTICE OF PUBLICATION   NPUBO
Jul-09-2002PUBLISHED FOR OPPOSITION   PUBOA
Oct-01-2002REGISTERED-PRINCIPAL REGISTER   R.PRA
Jun-27-2003TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Jun-27-2008CASE FILE IN TICRS   CFITO
Sep-02-2008TEAS SECTION 8 & 15 RECEIVED   E815I
Sep-04-2008ASSIGNED TO PARALEGAL   PLGLA
Sep-05-2008REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Aug-08-2011TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Sep-28-2012TEAS SECTION 8 & 9 RECEIVED   E89RI
Sep-29-2012REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Sep-29-2012REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)   RNL1Q
Sep-29-2012NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E
Aug-28-2016TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Oct-01-2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED   REM2E
Aug-09-2022TEAS SECTION 8 & 9 RECEIVED   E89RI
Feb-27-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Mar-01-2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Mar-01-2023REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)   RNL2Q
Mar-01-2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E